Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Cash flows from operating activities:
Net loss	$ (32,722,168)	$ (20,353,938)
Adjustments to reconcile net loss to net cash used in operating activities:
Stock-based compensation	4,668,815	2,379,360
Depreciation and amortization	86,073	34,515
Change in fair value of derivative instrument-warrants	0	6,050
Change in fair value of contingent consideration	2,310,000	140,000
Changes in operating assets and liabilities:
Accounts payable and accrued expenses	(1,067,847)	3,039,242
Right of use asset	252,803	241,421
Operating lease liability	(258,589)	(231,866)
Prepaid expenses and other assets	(4,493,568)	(1,419,986)
Net cash used in operating activities	(31,224,481)	(16,165,202)
Cash flows from investing activities:
Purchase of property and equipment	(130,405)	(87,983)
Proceeds from disposal of property and equipment	0	2,194
Net cash used in investing activities	(130,405)	(85,789)
Cash flows from financing activities:
Proceeds from the issuance of common stock, net of issuance costs	82,153,600	42,866,272
Proceeds from debt financing	0	176,585
Repayment of debt financing	(176,585)	0
Proceeds from the exercise of warrants	0	12,000
Net cash provided by financing activities	81,977,015	43,054,857
Net increase in cash	50,622,129	26,803,866
Cash at beginning of period	40,726,838	13,922,972
Cash at end of period	91,348,967	40,726,838
Supplementary disclosure of cash flow information:
Cash paid for interest	2,024	0
Supplementary disclosure of non-cash financing activities:
Conversion of Series C convertible preferred stock (part of Series C deemed dividend)	11,000	10,000
Fair value of warrants issued to placement agent	2,013,055	1,278,432
Adoption of new accounting standard	$ 11,672	$ 0